Christopher A. Natale

1.1k total citations
22 papers, 546 citations indexed

About

Christopher A. Natale is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christopher A. Natale has authored 22 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Christopher A. Natale's work include Immunotherapy and Immune Responses (8 papers), Estrogen and related hormone effects (6 papers) and Melanoma and MAPK Pathways (5 papers). Christopher A. Natale is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Estrogen and related hormone effects (6 papers) and Melanoma and MAPK Pathways (5 papers). Christopher A. Natale collaborates with scholars based in United States, Switzerland and Italy. Christopher A. Natale's co-authors include Todd W. Ridky, Ankit Dahal, Tzvete Dentchev, Junqian Zhang, Elizabeth K. Duperret, Brian C. Capell, Jinyang Li, Ben Z. Stanger, Shelley L. Berger and John T. Seykora and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher A. Natale

18 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher A. Natale United States 10 256 166 117 110 109 22 546
Jae-Bong Park South Korea 13 399 1.6× 100 0.6× 51 0.4× 82 0.7× 68 0.6× 24 623
Walbert J. Bakker Netherlands 12 559 2.2× 140 0.8× 59 0.5× 131 1.2× 98 0.9× 19 808
Claudia A. Benavente United States 15 376 1.5× 209 1.3× 28 0.2× 43 0.4× 78 0.7× 24 709
Kevin S. Pitel United States 10 342 1.3× 129 0.8× 131 1.1× 188 1.7× 56 0.5× 14 571
Nelson E. Brown Chile 15 353 1.4× 252 1.5× 72 0.6× 85 0.8× 59 0.5× 22 674
Peter Hovland United States 11 404 1.6× 191 1.2× 49 0.4× 36 0.3× 70 0.6× 16 773
Constanze Schwarz Germany 8 223 0.9× 91 0.5× 33 0.3× 51 0.5× 213 2.0× 14 512
Pierre-Yves Desprez United States 10 553 2.2× 250 1.5× 55 0.5× 312 2.8× 158 1.4× 12 932
Hector Macias United States 7 474 1.9× 292 1.8× 175 1.5× 43 0.4× 55 0.5× 9 910
Judith Campisi United States 4 355 1.4× 129 0.8× 32 0.3× 369 3.4× 104 1.0× 5 700

Countries citing papers authored by Christopher A. Natale

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Natale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Natale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Natale more than expected).

Fields of papers citing papers by Christopher A. Natale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Natale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Natale. The network helps show where Christopher A. Natale may publish in the future.

Co-authorship network of co-authors of Christopher A. Natale

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Natale. A scholar is included among the top collaborators of Christopher A. Natale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Natale. Christopher A. Natale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Natale, Christopher A., Israel Olayide, Christopher K. Arnatt, et al.. (2025). LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development. Cancer Research Communications. 5(4). 556–568.
2.
Cohen, Justine V., et al.. (2024). 1137P Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors. Annals of Oncology. 35. S746–S746. 1 indexed citations
3.
Visniauskas, Bruna, et al.. (2024). Ovariectomy-Induced Arterial Stiffening Differs From Vascular Aging and Is Reversed by GPER Activation. Hypertension. 81(5). e51–e62. 8 indexed citations
4.
Natale, Christopher A., et al.. (2024). An In Vivo Study of LNS8801, a GPER Agonist, in a Spontaneous Melanoma‐Prone Mouse Model, TGS. Pigment Cell & Melanoma Research. 38(1). e13197–e13197.
5.
Rodon, Jordi, Marya Chaney, Justine V. Cohen, et al.. (2023). 627 The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanoma. SHILAP Revista de lepidopterología. A716–A716.
6.
Ambrosini, Grazia, Christopher A. Natale, Elgilda Musi, Tina Garyantes, & Gary K. Schwartz. (2023). The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells. Cancer Research Communications. 3(4). 540–547. 10 indexed citations
7.
Natale, Christopher A., et al.. (2023). LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway. Cancer Research Communications. 3(8). 1594–1606. 2 indexed citations
8.
Rodón, Jordi, Marya Chaney, Justine V. Cohen, et al.. (2023). 1101P The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanoma. Annals of Oncology. 34. S663–S663. 3 indexed citations
9.
Natale, Christopher A., et al.. (2023). Monitoring cell fate in 3D organotypic human squamous epithelial cultures. STAR Protocols. 4(1). 102101–102101. 1 indexed citations
10.
Shoushtari, Alexander N., Marya Chaney, Justine V. Cohen, et al.. (2023). The effect of LNS8801 alone and in combination with pembrolizumab in patients with metastatic uveal melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9543–9543. 6 indexed citations
11.
Natale, Christopher A., Sung Hoon Kim, Yiliang Wei, et al.. (2022). Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling. Science Advances. 8(35). eabn4007–eabn4007. 14 indexed citations
12.
13.
Natale, Christopher A., Jinyang Li, Jason R. Pitarresi, et al.. (2020). Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. Cellular and Molecular Gastroenterology and Hepatology. 10(4). 868–880.e1. 44 indexed citations
14.
Natale, Christopher A., Jinyang Li, Junqian Zhang, et al.. (2018). Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade. eLife. 7. 99 indexed citations
15.
Natale, Christopher A., Elizabeth K. Duperret, Junqian Zhang, et al.. (2016). Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors. eLife. 5. 92 indexed citations
16.
Capell, Brian C., Adam Drake, Jiajun Zhu, et al.. (2016). MLL1 is essential for the senescence-associated secretory phenotype. Genes & Development. 30(3). 321–336. 118 indexed citations
17.
Duperret, Elizabeth K., et al.. (2016). The integrin αv-TGFβ signaling axis is necessary for epidermal proliferation during cutaneous wound healing. Cell Cycle. 15(15). 2077–2086. 27 indexed citations
18.
McNeal, Andrew S., Kevin Liu, Christopher A. Natale, et al.. (2015). CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma. Cancer Discovery. 5(10). 1072–1085. 64 indexed citations
19.
McNeal, Andrew S., Kevin Liu, Christopher A. Natale, et al.. (2015). Abstract 1239: CDKN2B loss promotes progression from benign melanocytic nevus to melanoma. Cancer Research. 75(15_Supplement). 1239–1239.
20.
Stella, Alessandro, Daniela Barana, Cristina Oliani, et al.. (2007). Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Clinical Genetics. 71(2). 130–139. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jae-Bong Park Breakdown of academic impact, for papers by Walbert J. Bakker Breakdown of academic impact, for papers by Claudia A. Benavente Breakdown of academic impact, for papers by Kevin S. Pitel Breakdown of academic impact, for papers by Nelson E. Brown Breakdown of academic impact, for papers by Peter Hovland Breakdown of academic impact, for papers by Constanze Schwarz Breakdown of academic impact, for papers by Pierre-Yves Desprez Breakdown of academic impact, for papers by Hector Macias Breakdown of academic impact, for papers by Judith Campisi
Rankless by CCL
2026